反応 #8264
ord-4d6e3d9e1bbd4dc7b675038819d674a7
反応方程式
試薬
反応条件
後処理
- 1ろ過The mixture was filtered through celite
- 2その他the residue after evaporation
- 3その他partitioned between ethyl acetate (10 ml) and aqueous sodium bicarbonate (15 ml)
- 4洗浄The organic phase was washed with sodium bicarbonate (2×15 ml), water (15 ml)
- 5乾燥dried (magnesium sulfate)
- 6その他evaporated
- 7その他The crude product was purified by chromatography on a 10 g Biotage silica column
- 8洗浄eluting with a gradient from dichloromethane to ethyl acetate
実験手順
3-(4-(3(S)-(2-Methoxyethoxycarbonylamino)pyrrolidin-1-yl)-3-fluorophenyl)-5(R)-(N-(2,2,2-trichloroethyloxycarbonyl)isoxazol-3-ylaminomethyl)oxazolidin-2-one (400 mg, 0.5 mM) was stirred in a mixture of acetic acid (10 ml) and water (2 ml). Zinc dust (203 mg, 3.1 mM) was added, and the mixture stirred 30 minutes at ambient temperature. The mixture was filtered through celite, and the residue after evaporation partitioned between ethyl acetate (10 ml) and aqueous sodium bicarbonate (15 ml). The organic phase was washed with sodium bicarbonate (2×15 ml), water (15 ml), dried (magnesium sulfate), and evaporated. The crude product was purified by chromatography on a 10 g Biotage silica column, eluting with a gradient from dichloromethane to ethyl acetate. Relevant fractions were combined to give the desired product (141 mg).